Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current HIV/AIDS Reports
Published in: Current HIV/AIDS Reports 6/2019

01-12-2019 | Human Immunodeficiency Virus | The Global Epidemic (SH Vermund, Section Editor)

Evolving HIV Epidemiology in Mainland China: 2009–2018

Authors: Yingying Ding, Zhonghui Ma, Jiayu He, Xiaoyi Xu, Shijie Qiao, Lulu Xu, Ruizi Shi, Xiaohui Xu, Bowen Zhu, Jing Li, Frank Y. Wong, Na He

Published in: Current HIV/AIDS Reports | Issue 6/2019

Login to get access

Abstract

Purpose of Review

This review is intended to provide an overview of the evolution of HIV epidemiology over the past decade in China.

Recent Findings

We provided a succinct overall view of the epidemic, followed by surveillance data, profiles of key populations, HIV molecular epidemiology, and drug resistance, as well as survival in the age of antiretroviral therapy usage. For each topical issue, we first reviewed the latest empirical evidence, followed by a brief summary assessment. We briefly addressed the challenges and opportunities of the next generation of HIV control and prevention efforts in China.

Summary

Notably, macro-social factors need to be integrated into the next generation of clinical and/or behavioral HIV research to inform disease progression and management, as well as control and prevention.
Literature
1.
National Health and Family Planning Commission of the People’s Republic of China. 2012 China AIDS response progress report. Beijing, China: 2012.
2.
National Center for AIDS & STD Control and Prevention, The Chinese Center for Disease Control and Prevention (CDC). Annals of information on comprehensive prevention and treatment for AIDS, STD and hepatitis C. 2018.
3.
Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China’s response to HIV/AIDS. Lancet. 2007;369(9562):679–90.PubMed
4.
Lu L, Jia M, Ma Y, Yang L, Chen Z, Ho DD, et al. The changing face of HIV in China. Nature. 2008;455(7213):609–11.PubMed
5.
Gao Y, Feng XF, Wen J, Hei FX, Ding GW, Pang L. Spatio-temporal distribution and correlation of reported cases of hepatitis C and HIV/AIDS in China, 2012-2017. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(2):155–9.PubMed
6.
Wu Z, Liu Z, Detels R. HIV-1 infection in commercial plasma donors in China. Lancet. 1995;346(8966):61–2.PubMed
7.
WHO. Increasing access to HIV testing and counseling. Geneva: Report of a WHO Consultation; 2002.
8.
Ran YH, Li H, Sun JP. Voluntary HIV counseling and testing: global development and status in China. Chin J AIDS STDs. 2008;14(2):204–6.
9.
Niu L, Wang Z, Fang Y, Ip M, Lau JTF. Behavior intention to use routine opt-out HIV testing in primary care settings among men who have sex with men in China. AIDS Care. 2019;31(12):1565–73 1–9.PubMed
10.
Tucker JD, Walensky RP, Yang LG, Yang B, Bangsberg DR, Chen XS, et al. Expanding provider-initiated HIV testing at STI clinics in China. AIDS Care. 2012;24(10):1316–9.PubMedPubMedCentral
11.
Tao J, Li MY, Qian HZ, Wang LJ, Zhang Z, Ding HF, et al. Home-based HIV testing for men who have sex with men in China: a novel community-based partnership to complement government programs. PLoS One. 2014;9(7):e102812.PubMedPubMedCentral
12.
Wu Z, Sun X, Sullivan SG, Detels R. Public health. HIV testing in China. Science. 2006;312(5779):1475–6.PubMed
13.
Wu Z, Xu J, Liu E, Mao Y, Xiao Y, Sun X. et al; National MSM Survey Group. HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China. Clin Infect Dis. 2013;57(2):298–309.PubMedPubMedCentral
14.
Cui Y, Guo W, Li D, Wang L, Shi CX, Brookmeyer R, et al. Estimating HIV incidence among key affected populations in China from serial cross-sectional surveys in 2010-2014. J Int AIDS Soc. 2016;19(1):20609.PubMedPubMedCentral
15.
Qin Q, Tang W, Ge L, Li D, Mahapatra T, Wang L, et al. Changing trend of HIV, syphilis and hepatitis C among men who have sex with men in China. Sci Rep. 2016;6(1):31081.PubMedPubMedCentral
16.
Chen Q, Sun Y, Sun W, Hao M, Li G, Su X, et al. Trends of HIV incidence and prevalence among men who have sex with men in Beijing, China: nine consecutive cross-sectional surveys, 2008-2016. PLoS One. 2018;13(8):e201953.
17.
Chen Y, Tang W, Chen L, Shi L, Liu X, Xu J, et al. Changing epidemic of HIV and syphilis among resident and migrant men who have sex with men in Jiangsu. China Sci Rep. 2017;7(1):9478.PubMed
18.
Wang Q, Chen X, Yin Y, Liang G, Zhang R, Jiang N, et al. HIV prevalence, incidence and risk behaviours among men who have sex with men in Yangzhou and Guangzhou, China: a cohort study. J Int AIDS Soc. 2014;17(1):18849.PubMedPubMedCentral
19.
Huan X, Hao C, Yan H, Guan W, Xu X, Yang H, et al. High prevalence of HIV and syphilis among men who have sex with men recruited by respondent-driven sampling in a city in Eastern China. Asia Pac J Public Health. 2015;27(2):P854–65.
20.
Tang W, Babu GR, Li J, Zhang Y, Fu G, Huan X, et al. The difference between HIV and syphilis prevalence and incidence cases: results from a cohort study in Nanjing, China, 2008–2010. Int J STD AIDS. 2014;26(9):648–55.PubMedPubMedCentral
21.
Shen L, Liu X, Fu G, Hao S, Zhang M, Wang T, et al. The epidemic of human immunodeficiency virus, hepatitis C virus, and syphilis infection, and the correlates of sexually transmitted infections among men who have sex with men in Zhenjiang, Jiangsu. China Jpn J Infect Dis. 2017;70(2):171–6.PubMed
22.
Yang HT, Tang W, Xiao ZP, Jiang N, Mahapatra T, Huan XP, et al. Worsening epidemic of HIV and syphilis among men who have sex with men in Jiangsu Province. China Clin Infect Dis. 2014;58(12):1753–9.PubMed
23.
Gao W, Li Z, Li Y, Qiao X. Sexual practices and the prevalence of HIV and syphilis among men who have sex with men in Lanzhou. China Jpn J Infect Dis. 2015;68(5):370–5.PubMed
24.
Hong H, Xu J, McGoogan J, Dong H, Xu G, Wu Z. Relationship between the use of gay mobile phone applications and HIV infection among men who have sex with men in Ningbo, China: a cross-sectional study. Int J STD AIDS. 2017;29(5):491–7.PubMed
25.
Ma Q, Zeng S, Xia S, Pan X, Wang D, Zhu H, et al. Risky sexual networks and concentrated HIV epidemics among men who have sex with men in Wenzhou, China: a respondent-driven sampling study. BMC Public Health. 2015;15(1):1246.PubMedPubMedCentral
26.
Ning Z, Fu J, Zhuang M, Park JA, Ibragimov U, He N, et al. HIV and syphilis epidemic among MSM and non- MSM aged 50 and above in Shanghai, China: a yearly cross-sectional study, 2008-2014. Glob Public Health. 2018;13(11):1625–33.PubMed
27.
Dai W, Luo Z, Xu R, Zhao G, Tu D, Yang L, et al. Prevalence of HIV and syphilis co-infection and associated factors among non-commercial men who have sex with men attending a sexually transmitted disease clinic in Shenzhen. China BMC Infect Dis. 2017;17(1):86.PubMed
28.
Hu J, Gu X, Tao X, Qian Y, Babu GR, Wang G, et al. Prevalence and trends of HIV, syphilis, and HCV in migrant and resident men who have sex with men in Shandong, China: results from a serial cross-sectional study. PLoS One. 2017;12(1):e170443.
29.
Feng Y, Bu K, Li M, Zhang X, Jin S, Wang L. Meta-analysis of HIV infection incidence and risk factors among men who have sex with men in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36(7):752–8.PubMed
30.
Xu J, Tang W, Zou H, Mahapatra T, Hu Q, Fu G, et al. High HIV incidence epidemic among men who have sex with men in china: results from a multi-site cross-sectional study. Infect Dis Poverty. 2016;5(1):82.PubMedPubMedCentral
31.
Han M, Pan PL, Wu GH, Zhou C, Yao Y, Luo J, et al. Estimating HIV incidence rates among MSM in an urban area of Chongqing using three approaches. Biomed Environ Sci. 2017;30(12):913–6.PubMed
32.
Zhang J, Xu J, Song W, Pan S, Chu Z, Hu Q, et al. HIV incidence and care linkage among MSM first-time-testers in Shenyang, China, 2012–2014. AIDS Behav. 2018;22(3):711–21.PubMed
33.
Yang H, Ye L, Su L, Liu Y, Xiao L, Hu Y, et al. An analysis on incidence of HIV-1 epidemics among men who have sex with men in Sichuan Province during 2011-2015. Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53(3):327–9.PubMed
34.
Tang S, Tang W, Meyers K, Chan P, Chen Z, Tucker JD. HIV epidemiology and responses among men who have sex with men and transgender individuals in China: a scoping review. BMC Infect Dis. 2016;16(1):588.PubMedPubMedCentral
35.
Zhang L, Chow EP, Su S, Yiu WL, Zhang X, Iu KI, et al. A systematic review and meta-analysis of the prevalence, trends, and geographical distribution of HIV among Chinese female sex workers (2000-2011): implications for preventing sexually transmitted HIV. Int J Infect Dis. 2015;39:76–86.PubMed
36.
Zhu J, Yuan R, Hu D, Zhu Z, Wang N, Wang B. HIV prevalence and correlated factors of female sex workers and male clients in a border region of Yunnan Province. China Int J STD AIDS. 2018;29(5):424–34.PubMed
37.
Yang H, Su L, Ye L, Xiao L, Hu Y, Shen MG, et al. Incidence rates of HIV-1 epidemics among 4 high risk groups in Sichuan province during 2011-2015. Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38(12):1649–54.PubMed
38.
Yang YC, Shi RZ, Tang RH, Ye RH, Wang JB, Duan X, et al. Estimating HIV incidence among female sex workers and injection drug users in Dehong Prefecture, 2009-2017. Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52(12):1243–7.PubMed
39.
Wang C, Guo Q, Han Z, Chen D. Awareness rate of HIV/AIDS core knowledge among the elderly: a meta-analysis. Chin J AIDS STD. 2019;2:148–52.
40.
41.
Wang LY, Qin QQ, Ge L, Ding ZW, Cai C, Guo W, et al. Characteristics of HIV infections among over 50-year-olds population in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37(2):222–6.PubMed
42.
Chen H, Wu X, Chen L, Lu H, Tang Z, Shen Z, et al. Rapidly spreading HIV epidemic among older males and associated factors: a large-scale prospective cohort study in rural southwest China. Sex Transm Dis. 2019;46(4):234–9.PubMed
43.
• Li G, Jiang Y, Zhang L. HIV upsurge in China’s students. Science. 2019;364(6442):711. This study reports the recent increase in HIV infection among China's college students. PubMed
44.
He N, Duan S, Ding Y, Rou K, McGoogan JM, Jia M, et al. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One. 2013;8(11):e77981.PubMedPubMedCentral
45.
Jia Z, Mao Y, Zhang F, Ruan Y, Ma Y, Li J, et al. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study. Lancet. 2013;382(9899):1195–203.PubMed
46.
He X, Xing H, Ruan Y, Hong K, Cheng C, Hu Y, et al. A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS One. 2012;7(10):e47289.PubMedPubMedCentral
47.
Yuan R, Cheng H, Chen LS, Zhang X, Wang B. Prevalence of different HIV-1 subtypes in sexual transmission in China: a systematic review and meta-analysis. Epidemiol Infect. 2016;144(10):2144–53.PubMed
48.
Xiao P, Li J, Fu G, Zhou Y, Huan X, Yang H. Geographic distribution and temporal trends of HIV-1 subtypes through heterosexual transmission in China: a systematic review and meta-analysis. Int J Environ Res Public Health. 2017;14(7):E830.PubMed
49.
Yin Y, Liu Y, Zhu J, Hong X, Yuan R, Fu G, et al. The prevalence, temporal trends, and geographical distribution of HIV-1 subtypes among men who have sex with men in China: a systematic review and meta-analysis. Epidemiol Infect. 2019;147:e83.PubMedPubMedCentral
50.
Liu H, Ma Y, Su Y, Smith MK, Liu Y, Jin Y, et al. Emerging trends of HIV drug resistance in Chinese HIV-infected patients receiving first-line highly active antiretroviral therapy: a systematic review and meta-analysis. Clin Infect Dis. 2014;59(10):1495–502.PubMedPubMedCentral
51.
Zuo Z, Liang S, Sun X, Bussell S, Yan J, Kan W, et al. Drug resistance and virological failure among HIV-infected patients after a decade of antiretroviral treatment expansion in eight provinces of China. PLoS One. 2016;11(12):e0166661.PubMedPubMedCentral
52.
Dong K, Ye L, Leng Y, Liang S, Feng L, Yang H, et al. Prevalence of HIV-1 drug resistance among patients with antiretroviral therapy failure in Sichuan, China, 2010-2016. Tohoku J Exp Med. 2019;247(1):1–12.PubMed
53.
Zhao S, Feng Y, Hu J, Li Y, Zuo Z, Yan J, et al. Prevalence of transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China. Sci Rep. 2018;8(1):12273.PubMedPubMedCentral
54.
Sun DY, Liu J, Xu W, He C, Yan J, Xing H, et al. Diversity of HIV-1 subtypes and primary HIV-1 drug resistance among 302 newly confirmed HIV infections/AIDS in Henan province, China. Zhonghua Yu Fang Yi Xue Za Zhi. 2016;50(8):733–7.PubMed
55.
Zheng MN, Ning TL, Zhou N, Zhao X, Li L, Zhu JJ, et al. Transmitted drug resistance among HIV infected men who have sex with men in Tianjin, 2014-2017. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(5):619–24.PubMed
56.
Xu Y, Peng X, Peng X, Ji S, Chen B, Wang L, et al. Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017. Arch Virol. 2018;163(8):2233–7.PubMed
57.
Song YX, Xin RL, Li ZC, Yu HW, Lun WH, Ye J, et al. Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing. Epidemiol Infect. 2018;146(3):339–44.PubMed
58.
Wang X, Liu X, Li F, Zhou H, Li J, Wang Y, et al. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015. PLoS One. 2018;13(6):e0198005.PubMedPubMedCentral
59.
Chen R, Liang B, Wen B, Huang G, Ning C, Lao C, et al. No difference in prevalence of transmitted drug resistance between injection drug users and non-injection drug users: a cross-sectional study among antiretroviral treatment-naïve HIV patients. Intervirology. 2018;61(6):281–91.PubMed
60.
• Wang Z, Zhang M, Zhang R, Liu L, Shen Y, Wang J, et al. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai. China BMC Infect Dis. 2019;19(1):313. The study reports that distribution of HIV-1 genotypes in Shanghai China is diverse and complex, and highlights the significance of baseline HIV-1 drug resistance testing.
61.
Dong AB, Xiao L, Liang S, Liu L, Kang RH, Zhao S, et al. HIV-1 drug resistance and influencing factors among people living with HIV/AIDS before antiretroviral therapy in Liangshan Yi Autonomous Prefecture. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(6):648–53.PubMed
62.
Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med. 2009;151(4):241–51 W-52.PubMed
63.
Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11(7):516–24.PubMed
64.
Dou Z, Zhang F, Zhao Y, Jin C, Zhao D, Gan X, et al. Progress on China’ s national free antiretroviral therapy strategy in 2002-2014. Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36(12):1345–50.PubMed
65.
Chen M, Dou Z, Wang L, Wu Y, Zhao D, Gan X, et al. Gender differences in outcomes of antiretroviral treatment among HIV-infected patients in China: a retrospective cohort study, 2010-2015. J Acquir Immune Defic Syndr. 2017;76(3):281–8.PubMed
66.
Ma Y, Dou Z, Guo W, Mao Y, Zhang F, McGoogan JM, et al. The human immunodeficiency virus care continuum in China: 1985-2015. Clin Infect Dis. 2018;66(6):833–9.PubMed
67.
Zhao Y, Wu Z, McGoogan JM, Shi CX, Li A, Dou Z, et al. Immediate antiretroviral therapy decreases mortality among patients with high CD4 counts in China: a nationwide, retrospective cohort study. Clin Infect Dis. 2018;66(5):727–34.PubMed
68.
•• Zhao Y, Wu Z, McGoogan JM, Sha Y, Zhao D, Ma Y, et al. Nationwide cohort study of antiretroviral therapy timing: treatment dropout and virological failure in China, 2011-2015. Clin Infect Dis. 2019;68(1):43–50. This national cohort study demonstrates that immediate ART is associated with reduced treatment dropout and virological failure. PubMedCentral
69.
Chow EP, Wilson DP, Zhang L. What is the potential for bisexual men in China to act as a bridge of HIV transmission to the female population?Behavioural evidence from a systematic review and meta-analysis. BMC Infect Dis. 2011;11:242.PubMedPubMedCentral
70.
Lau JT, Wang M, Wong HN, Tsui HY, Jia M, Cheng F, et al. Prevalence of bisexual behaviors among men who have sex with men (MSM) in China and associations between condom use in MSM and heterosexual behaviors. SexTransm Dis. 2008;35:406–13.
71.
Ding Y, Yan H, Ning Z, Cai X, Yang Y, Pan R, et al. Low willingness and actual uptake of pre-exposure prophylaxis for HIV-1 prevention among men who have sex with men in Shanghai. China Biosci Trends. 2016;10(2):113–9.PubMed
72.
Liu C, Ding Y, Zhen N, Gao M, Liu X, Wong FY, et al. Factors associated with uptake of HIV pre-exposure prophylaxis: some qualitative insights from an intervention study of men who have sex with men in China. Sex Health. 2018;15(1):39–45.PubMed
73.
Hua J, Lin H, Ding Y, Qiu D, Wong FY, He N. HIV drug resistance in newly diagnosed adults in a rural prefecture of Eastern China. Epidemiol Infect. 2015;143(3):663–72.PubMed
74.
Diaz RM, Ayala G, Bein E, Henne J, Marin BV. The impact of homophobia, poverty, and racism on the mental health of gay and bisexual Latino men: findings from 3 US cities. Am J Public Health. 2001;91(6):927.PubMedPubMedCentral
75.
Brown JR, O’Connor GT. Coronary heart disease and prevention in the United States. N Engl J Med. 2010;362(23):2150–3.PubMed
76.
Galea S, Ahern J, Nandi A, Tracy M, Beard J, Vlahov D. Urban neighborhood poverty and the incidence of depression in a population-based cohort study. Ann Epidemiol. 2007;17(3):171–9.PubMedPubMedCentral
77.
Belle D, Doucet J. Poverty, inequality, and discrimination as sources of depression among US women. Psychol Women Q. 2003;27(2):101–13.
78.
Singer M Introduction to syndemics: a critical systems approach to public and community health. John Wiley & Sons; 2009.
79.
Stall R, Mills TC, Williamson J, Hart T, Greenwood G, Paul J, et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93(6):939–42.PubMedPubMedCentral
Metadata
Title
Evolving HIV Epidemiology in Mainland China: 2009–2018
Authors
Yingying Ding
Zhonghui Ma
Jiayu He
Xiaoyi Xu
Shijie Qiao
Lulu Xu
Ruizi Shi
Xiaohui Xu
Bowen Zhu
Jing Li
Frank Y. Wong
Na He
Publication date
01-12-2019
Publisher
Springer US
Published in
Current HIV/AIDS Reports / Issue 6/2019
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-019-00468-z

Other articles of this Issue 6/2019

Current HIV/AIDS Reports 6/2019 Go to the issue

Complications of HIV and Antiretroviral Therapy (GA McComsey, Section Editor)

Aging with HIV

Implementation Science (E Geng, Section Editor)

Peer Support for Adolescents and Young People Living with HIV in sub-Saharan Africa: Emerging Insights and a Methodological Agenda

HIV Pathogenesis and Treatment (AL Landay and NS Utay, Section Editors)

Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework

The Global Epidemic (SH Vermund, Section Editor)

Interventions to improve the HIV continuum of care in China

The Global Epidemic (SH Vermund, Section Editor)

HIV and Aging in Mainland China: Implications for Control and Prevention Research

The Global Epidemic (SH Vermund, Section Editor)

History of the HIV Epidemic in China
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits